Can-Fite BioPharma CANF Balance Sheet (2013-2026)

NYSE CANF
$2.22 -0.07 (-3.06%)
As of: Sep 9, 2026 · 3:58 PM EDT
Reported Financials

Can-Fite BioPharma Quarterly Balance Sheet

Periods 46 quarters
Latest Jun 2026

Can-Fite BioPharma reported total assets of $8.05M and total liabilities of $3.20M for the quarter ended Jun 2026, up 36.0% year over year. This balance sheet covers 46 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2013 Sep2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
9.06M10.22M8.27M2.74M1.02M5.81M4.39M5.50M1.71M3.73M2.98M1.26M3.46M3.38M4.28M4.72M4.83M6.45M5.53M2.98M
Short-term InvestmentsInvestments (Current)
0.08M0.07M0.36M6.51M7.50M14.51M0.18M0.04M0.01M5.00M0.02M0.01M0.00M0.02M0.01M3.06M0.00M3.01M0.01M
Cash & Current Investments
9.14M10.22M8.34M3.11M7.54M13.31M18.90M5.69M1.75M3.74M7.98M1.28M3.47M3.39M4.30M4.73M7.88M6.46M8.54M2.99M
Receivables - NetNet Receivables
3.57M
Receivables - OtherOther Receivables
1.06M0.93M1.17M
Receivables
3.57M
Prepaid Assets
3.57M1.06M1.02M1.75M0.81M0.93M0.97M1.82M1.75M1.17M0.96M1.29M1.12M0.99M1.10M1.09M1.17M0.90M0.96M
Current Assets
12.70M9.40M12.62M9.55M14.47M20.07M17.67M14.59M12.56M9.16M13.38M10.91M9.06M9.91M5.83M8.98M7.62M9.44M8.00M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.03M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.04M0.04M0.04M0.04M0.03M0.03M0.03M0.03M0.01M0.01M0.01M
Long-Term Investments
Long-Term Deferred Tax
35.89M28.63M25.14M25.61M28.06M34.09M
Other Non-Current Assets
Non-Current Assets
0.10M0.12M0.12M0.13M0.17M0.18M0.17M0.16M0.14M0.13M0.11M0.12M0.10M0.08M0.09M0.14M0.10M0.07M0.05M
Assets
12.80M13.33M9.52M12.74M9.68M14.64M20.25M17.85M14.75M12.71M9.28M13.49M11.03M9.17M9.99M5.92M9.12M7.72M9.51M8.05M
Liabilities
Current Liabilities
Accounts Payables
0.44M0.78M0.56M0.29M1.00M0.81M0.95M1.12M0.82M1.47M0.90M0.96M0.81M0.65M0.43M0.89M0.62M1.15M1.16M0.68M
Notes Payables
Payables
0.44M0.78M0.56M0.29M1.00M0.81M0.95M1.12M0.82M1.47M0.90M0.96M0.81M0.65M0.43M0.89M0.62M1.15M1.16M0.68M
Accumulated Expenses
0.47M0.40M0.33M0.73M0.31M0.30M0.91M0.91M0.46M0.46M0.78M1.10M0.60M0.75M0.94M0.43M0.98M0.51M1.11M1.09M
Other Accumulated Expenses
2.68M
Current Leases
0.04M0.03M0.04M0.04M0.04M0.04M0.05M0.06M0.05M0.05M0.05M0.04M0.04M0.03M0.03M0.04M0.05M0.06M0.06M0.05M
Current Taxes
Current Deferred Revenue
0.56M0.60M0.33M1.00M1.00M1.00M0.82M0.82M0.82M0.82M0.78M0.78M0.78M0.78M0.62M0.64M0.41M0.41M0.41M0.41M
Curent Deferred Tax LiabilityCurent Deferred Tax
1.18M0.97M
Total Current Liabilities
1.50M1.82M1.27M2.06M2.36M2.15M2.73M2.90M2.15M2.80M2.50M2.89M2.23M2.21M2.02M1.99M2.05M2.12M2.73M2.23M
Non-Current Liabilities
Non-Current Deffered Revenue
2.12M1.95M2.16M3.59M3.34M3.09M3.07M2.87M2.66M2.46M2.29M2.10M1.90M1.71M1.71M1.44M1.58M1.38M1.18M0.97M
Pension
Minority Interest
Operating Leases
0.02M0.01M0.02M0.01M0.03M0.06M0.07M0.05M0.04M0.03M0.01M0.01M0.02M0.02M0.01M0.02M0.05M0.03M0.01M0.00M
Other Non-Current Liabilities
Total Non-Current Liabilities
2.14M1.97M2.18M3.60M3.37M3.15M3.14M2.92M2.70M2.48M2.31M2.10M1.93M1.72M1.73M1.46M1.63M1.42M1.19M0.97M
Total Liabilities
3.64M3.79M3.45M5.66M5.72M5.30M5.87M5.82M4.85M5.28M4.81M5.00M4.16M3.93M3.75M3.44M3.68M1.05M3.92M3.20M
Shareholder's Equity
Total Debt
Common Equity
9.16M9.54M6.07M7.08M3.96M9.33M14.38M12.02M9.89M7.43M4.47M8.49M6.87M5.24M6.24M2.48M5.44M6.67M5.59M4.86M
Liabilities and Shareholders Equity
12.80M13.33M9.52M12.74M9.68M14.64M20.25M17.85M14.75M12.71M9.28M13.49M11.03M9.17M9.99M5.92M9.12M7.72M9.51M8.05M
Treasury Shares
Retained Earnings
-119.26M-121.84M-125.47M-127.35M-130.57M-133.97M-140.67M-143.11M-145.30M-147.83M-150.85M-153.40M-155.07M-156.83M-158.48M-162.44M-166.36M-171.24M-176.19M-180.79M